Synthesis and biological evaluation of a series of hydroxybenzylphenylamine derivatives as inhibitors of EGF receptor-associated tyrosine kinase activity

Anti-Cancer Drug Design

Volumn 11, Issue 1, 1996, Pages 49-71

  Chen, H ^a   Bashiardes, G ^b   Mailliet, P ^b   Commercon, A ^b   Sounigo, F ^a   Boiziau, J ^b   Parker, F ^b   Tocque, B ^b   Roques, B P ^a   Garbay, C ^a  

^a Laboratoire de Pharmacochimie   (France)

^b SANOFI   (France)

Author keywords

Biological activity; Hydroxybenzylphenylamine derivatives; Proteintyrosine kinase inhibitors; Synthesis

Indexed keywords

ALCOHOL; AMIDE; ANILINE DERIVATIVE; ENZYME INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR KINASE; ETHER; KETONE; NITRILE; THIOAMIDE;

ANIMAL CELL; ARTICLE; CHEMICAL STRUCTURE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; DRUG ACTIVITY; DRUG SYNTHESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

ANILINE COMPOUNDS; ANIMALS; CELL DIVISION; CELL MEMBRANE; CRICETINAE; DNA; ENZYME INHIBITORS; GROWTH INHIBITORS; HUMANS; KINETICS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSFECTION;

ANIMALIA;

EID: 13344287062     PISSN: 02669536     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. BARKER, A.J. & DAVIES, D.H. (1992). Quinazoline tyrosine kinase inhibitors. Imperial Chemical Industries Co. Ltd, E.P. 530, 722.
2. BISHOP, J.M. (1987). The molecular genetics of cancer. Science, 235, 305.
3. BISHOP, J.M. (1991). Molecular themes in oncogenesis. Cell, 64, 235.
4. BURKE, T.R., JR (1992). Protein-tyrosine kinase inhibitors. Drugs of the Future, 17, 119.
5. BURKE, T.R., JR, FORD, H., OSHEROV, N., LEVITSKI, A., STEFANOVA, I., HORAK, I.D. & MARQUEZ, V.E. (1992). Arylamides of hydroxylated isoquinolines as protein-tyrosine kinase inhibitors. Bioorganic and Medicinal Chemistry Letters, 2, 1771.
6. CARPENTER, G., KING, L., JR & COHEN, S. (1979). Rapid enhancement of protein phosphorylation in A-431 cell membrane preparations by epidermal growth factor. Journal of Biological Chemistry, 254, 4884.
7. CASEY, M.L., KEMP, D.S., PAUL, K.G. & COX, G.G. (1973). The physical organic chemistry of benzisoxazoles. I. The mechanism of the base-catalysed decomposition of benzisoxazoles. Journal of Organic Chemistry, 38, 2294.
8. CERNY, T., BARNES, D.M., HASLETON, P., BARBER, P.V., HEALY, K., GULLICK, W. & THATCHER, N. (1986). Expression of epidermal growth factor receptor (EGF-R) in human lung tumours. British Journal of Cancer, 54, 265.
9. CHANG, C.J. & GEAHLEN, R.L. (1992). Protein-tyrosine kinase inhibition: mechanism-based discovery of antitumor agents. Journal of Natural Products, 55, 1529.
10. CHEN, H., BOIZIAU, J., PARKER, F., MAROUN, R., TOCQUE, B., ROQUES, B.P. & GARBAY-JAUREGUIBERRY, C. (1993). Synthesis and structure-activity studies of a series of ((hydroxybenzyl) amino)salicylates as inhibitors of EGF receptor-associated tyrosine kinase activity. Journal of Medicinal Chemistry, 36, 4094.
11. CHEN, H., BOIZIAU, J., PARKER, F., MAILLIET, P., COMMERCON, A., TOCQUE, B., LE PECQ, J.B., ROQUES, B.P. & GARBAY, C. (1994). Structure-activity relationships in a series of 5-[(2,5-dihydroxybenzyl)amino]salicylate inhibitors of EGF receptor-associated tyrosine kinase: Importance of additional hydrophobic aromatic interactions. Journal of Medicinal Chemistry, 37, 845.
12. CLARK, G.M. & MCGUIRE, W.L. (1991). Follow-up study of HER-2/neu amplification in primary breast cancer. Cancer Research, 51, 944.
13. EKSTRAND, A.J., JAMES, C.D., CAVENEE, W.K., SELIGER, B., PETTERSSON, R.F. & COLLINS, V.P. (1991). Genes for epidermal growth factor receptor, transforming growth factor α, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Research, 51, 2164.
14. ERNEUX, C., COHEN S. & GARBERS, D.L. (1983). The kinetic of tyrosine phosphorylation by the purified epidermal growth factor receptor kinase of A-431 cells. Journal of Biological Chemistry. 258, 4137.
15. FRY, D.W., KRAKER, A.J., MCMICHAEL, A., AMBROSO, L.A., NELSON, J.M., LEOPOLD, W.R.. CONNORS, R.W. & BRIDGES, A.J. (1994). A specific inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase. Science, 265, 1093.
16. GAZIT, A., YAISH, P., GILON, C. & LEVITZKI, Y. (1989). Tyrphostins 1: Synthesis and biological activity of protein kinase inhibitors. Journal of Medicinal Chemistry, 32, 2344.
17. GAZIT, A., OSHEROV, N., POSNER, I., YAISH, P., PORADOSU. E., GILON, C. & LEVITSKI, A. (1991). Tyrphostins. 2. Heterocyclic and α-substituted benzylidenemalononitrile tyrphostins as potent inhibitors of EGF receptor and Erb B2/neu tyrosine kinase. Journal of Medicinal Chemistry, 34, 1896.
18. GEISSLER, J.F., TRAXLER, P., REGENASS, U., MURRAY, B.J., ROESEL, J.L., MEYER, T., MCGLYNN, E., STORNI, AA. & LYDON, N.B. (1990). Thiazolidinediones. Biochemical and biological activity of a novel class of tyrosine protein kinase inhibitors. Journal of Biological Chemistry, 265, 22255.
19. HALABAN, R. (1991). Growth factor and tyrosine protein kinases in normal and malignant melanocytes. Cancer Metastasis Reviews, 10, 129.
20. HSU, C.J., PERSONS, P.E., SPADA, A.P., BEDNAR, R.A., LEVITSKI, A. & ZILBERSTEIN, A. (1991). Kinetic analysis of the inhibition of the epidermal growth factor receptor tyrosine kinase by Lavendustin-A and its analogue. Journal of Biological Chemistry, 266, 21105.
21. HSU, C.J., JACOSKI, M.V., MAGUIRE, M.P., SPADA, A.P. & ZILBERSTEIN, A. (1992). Inhibition kinetics and selectivity of the tyrosine kinase inhibitor erbstatin and a pyridone-based analogue. Biochemical Pharmacology, 43, 2471.
22. KIKKAWA, U., GO, M., KOUMOTO, J. & NISHIZUKA, Y. (1986). Rapid purification of protein kinase C by high performance liquid chromatography. Biochemical and Biophysical Research Communications, 135, 636.
23. KNIGHTON, D.R., CADENA, D.L., ZHENG, J., TEN EYCK, L., TAYLOR, S.S., SOWADSKI, J.M. & GILL, G.N. (1993). Structural features that specify tyrosine kinase activity deduced from homology modeling of the epidermal growth factor receptor. Proceedings of the National Academy of Sciences (USA), 90, 5001.
24. LEVITSKI, A. (1992). Tyrphostins: tyrosine kinase blockers as novel antiproliferative agents and dissectors of signal transduction. FASEB Journal, 6, 3275.
25. LIBERMANN, T.A., NUSBAUM, H.R., RAZON, N., KRIS, R., LAX, I., SOREQ, H., WHITTLE, N., WATERFIELD, M.D., ULLRICH, A. & SCHLESSINGER, J. (1985). Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature, 313, 144.
26. LUND-JOHANSEN, M., BJERKVIG, R., HUMPHREY, P.A., BIGNER, S.H., BIGNER, D.D. & LAERUM, O.D. (1990). Effect of epidermal growth factor on glioma cell growth, migration, and invasion in vitro. Cancer Research, 50, 6039.
27. MCCANN, A.H., DERVAN, P.A., O'REGAN, M., CODD, M.B., GULLICK, W.J., TOBIN, B.M., JR & CARNEY, D.N. (1991), Prognostic significance of c-erb-B-2 and estrogen receptor status in human breast cancer. Cancer Research, 51, 3296.
28. ONADA, T., IINUMA, H., SASAKI, Y., HAMADA, M., ISSHIKI, K., NAGANAWA, H., TAKEUCHI, K., TATSUTA, K. & UMEZAWA, K. (1989). Isolation of a novel tyrosine kinase inhibitor, Lavendustin, A, from Streptomyces griseolavendus. Journal of Natural Products, 52, 1252.
29. ONADA, T., ISSHIKI, K., TAKEUCHI, T., TATSUTA, K. & UMEZAWA, K. (1990). Inhibition of tyrosine kinase and epidermal growth factor receptor internalization by Lavendustin A methyl ester in cultured A431 cells. Drugs under Experimental and Clinical Research, 16, 249.
30. OSHEROV, N., GAZIT, A., GILON. C. & LEVITSKI, A. (1993). Selective inhibition of the epidermal growth factor and HER2/neu receptor by tyrphostins. Journal of Biological Chemistry, 268, 11134.
31. POSNER, I., ENGEL, M. & LEVITSKI, A. (1992). Kinetic model of the epidermal growth factor (EGF) receptor tyrosine kinase and a possible mechanism of its activation by EGF. Journal of Biological Chemistry, 267, 20638.
32. POSNER, I., ENGEL, M., GAZIT, A. & LEVITSKI, A. (1994). Kinetic of inhibition by tyrphostins of the tyrosine kinase activity of the epidermal growth factor receptor and analysis by a new computer program. Molecular Pharmacology, 45, 673.
33. SCHNEIDER, P.M., HUNG, M.C., CHIOCCA, S.M., MANNING, J., ZHAO, X., FANG, K. & ROTH, J.A. (1989). Differential expression of the c-erbB-2 gene in human small cell and non-small cell lung cancer. Cancer Research, 49, 4968.
34. SLAMON, D.J., GODOLPHIN, W., JONES, L.A., HOLT, J.A., WONG, S.G., KEITH, D.E., LEVIN, W.J., STUART, S.G., UDOVE, J., ULLRICH, A. & PRESS, M.F. (1991). Studies of the HER-2/neu protooncogene in human breast and ovarian cancer. Science, 244, 707.
35. SMITH, M.K., COLBRAN, R.J. & SODERLING, T.R. (1990). Specificities of autoinhibitory domain peptides for four protein kinases. Journal of Biological Chemistry, 265, 1837.
36. SOZZI, G., MIOZZO, M., TAGLIABUE, E., CALDERONE, C., LOMBARDI, L., PILOTTI, S., PASTORINO, U., PIEROTTI, M.A. & DELLA, PORTA, G.D. (1991). Cytogenetic abnormalities and overexpression of receptors for growth factors in normal bronchial epithelium and tumor samples of lung cancer patients. Cancer Research, 51, 400.
37. TATEISHI, M., ISHIDA, T., MITSUDOMI, T., KANEKO, S. & SUGIMACHI, K. (1990). Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung. Cancer Research, 50, 7077.
38. 60v-src protein tyrosine kinase. Journal of Medicinal Chemistry, 37, 598.
39. ULLRICH, A. & SCHLESSINGER, J. (1990). Signal transduction by receptor with tyrosine kinase activity. Cell, 61, 203.